Correspondence Re: Development, Validation and Results from the Impact of Treatment Evolution in Non-Small Cell Lung Cancer (iTEN) Model

In their recent paper in Lung Cancer titled “Development, Validation and Results from the Impact of Treatment Evolution in Non-Small Cell Lung Cancer (iTEN) Model”, Moldaver et al attempt to model treatment for incurable non-small cell lung cancer (NSCLC) using a discrete event simulation[1]. Using consensus treatment patterns and patient characteristics derived from cancer registry data, they set out to determine the cost of contemporary treatment.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research